Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Glenmark Pharma has received USFDA final approval for anti-bacterial drug

Glenmark Pharmaceuticals has got the US health regulator’s final approval for a generic version of anti-bacterial drug Zyvox.

The company said in a statement that “Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the US Food & Drug Administration (USFDA) for the Linezolid tablets, 600 mg.”

It further said that the product is the therapeutic equivalent of Zyvox tablets, 600 mg of Pharmacia and Upjohn Company, a subsidiary of Pfizer.

Read EquityPandit’s Nifty Pharma Outlook for this week

Get Daily Prediction & Stocks Tips On Your Mobile